HY-139915-10mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
HY-139915-100mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
HY-139915-25mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
HY-139915-5mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
HY-139915-50mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
HY-79593-10mg
|
MedChemexpress LLC
|
MRE-269 [CAS 475085-57-5]
|
|
COVID-19-immunoregulation
|
|
HY-79593-100mg
|
MedChemexpress LLC
|
MRE-269 [CAS 475085-57-5]
|
|
COVID-19-immunoregulation
|
|
HY-79593-5mg
|
MedChemexpress LLC
|
MRE-269 [CAS 475085-57-5]
|
|
COVID-19-immunoregulation
|
|
HY-79593-50mg
|
MedChemexpress LLC
|
MRE-269 [CAS 475085-57-5]
|
|
COVID-19-immunoregulation
|
|
HY-79593-1mL
|
MedChemexpress LLC
|
MRE-269 [CAS 475085-57-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-118773-10mg
|
MedChemexpress LLC
|
MreB Perturbing Compound A22 (hydrochloride) [CAS 22816-60-0]
|
|
COVID-19-immunoregulation
|
|
HY-118773-25mg
|
MedChemexpress LLC
|
MreB Perturbing Compound A22 (hydrochloride) [CAS 22816-60-0]
|
|
COVID-19-immunoregulation
|
|
HY-118773-5mg
|
MedChemexpress LLC
|
MreB Perturbing Compound A22 (hydrochloride) [CAS 22816-60-0]
|
|
COVID-19-immunoregulation
|
|
HY-145191-10mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-100mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-25mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-5mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-50mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-146220-10mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
HY-146220-100mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
HY-146220-25mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
HY-146220-5mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
HY-146220-50mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-8 [CAS 2768216-96-0]
|
|
COVID-19-immunoregulation
|
|
HY-145997-1mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
HY-145997-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|